EUVIMEDEUVIMED entdecken
Crossref

Resveratrol attenuates LPS/CSE-induced macrophage ferroptosis through activation of the Nrf2-ferroportin axis

Zhuozhe Li, Xu Ju, Mengjie Chen, Zhihong Chen, Zhilong Jiang

International Immunopharmacology · 2026-11 · 189 · 117380

DOI: 10.1016/j.intimp.2026.117380 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2026-11. Verfasst von Zhuozhe Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Resveratrol, Cation Transport Proteins, Macrophages. Die Arbeit nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Resveratrol (Res) has therapeutic effects in a mouse model with chronic obstructive pulmonary disease (COPD). However, the role of ferroportin (FPN) in the Res-mediated therapeutic effects remains unclear. PURPOSE: We investigated the role and signaling pathways of FPN in macrophages and a mouse model with acute exacerbation of COPD (AECOPD) after Res treatment. STUDY DESIGN/METHODS: Res was intraperitoneal (i.p.) injected into AECOPD-like mouse model or added into cultured macrophages prior to LPS/CSE treatment. Macrophages with FPN knockdown and over-expression were established by infection of the cells with lentiviral vector encoding FPN shRNA and cDNA. RESULTS: Res i.p. suppressed pulmonary infiltration of neutrophils and emphysema in the LPS/CSE-treated mice, in association with upregulated expression of FPN. LPS, CSE and their mixture increased the expression of FPN, TNF-α and IL-6 in macrophages, with increased hemosiderin deposits, reactive oxygen species (ROS) and malondialdehyde (MDA), but the effects were reversed by pre-treatment with Res. In addition, Res activated nuclear factor erythroid 2-related factor 2 (Nrf2) and NAD-dependent protein deacetylase sirtuin-1 (SIRT1), that was reversed by their inhibitors Brusatol and EX527, and subsequently abolished Res-induced upregulation of FPN in the treated cells. Knock-down of FPN partially reduced Res-mediated suppression of macrophage ferroptosis, whereas over-expression of FPN enhanced the effects. Adoptive transfer of FPN over-expressing bone marrow-derived macrophages (BMDMs) reduced lung inflammation and injury, in association with reduced lung neutrophil infiltrates, and expression of TNF-α, IL-6 in the treated mice. CONCLUSION: Res suppressed AECOPD partially through activation of Nrf2/FPN signaling and subsequent suppression of macrophage ferroptosis. FPN would be a potential therapeutic target in the treatment of AECOPD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-E2-Related Factor 2ResveratrolCation Transport ProteinsMacrophagesFerroptosisPulmonary Disease, Chronic ObstructiveAnimalsFerroportinLipopolysaccharidesMiceMaleMice, Inbred C57BLSignal TransductionDisease Models, AnimalHumansLung

Stichwörter der Autor:innen

AECOPDFerroportin (FPN)FerroptosisMacrophagesResveratrol

Substanzen

NF-E2-Related Factor 2ResveratrolCation Transport ProteinsFerroportinLipopolysaccharidesNfe2l2 protein, mouse

Autor:innen und Institutionen

  • Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Department of Respiratory and Critical Care Medicine, Shanghai Jing'an District Zhabei Central Hospital, Shanghai, China.
  • Department of Pulmonary and Critical Care Medicine, Xinhua Hospital, Institute of Respiratory Diseases, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address: chenzhihong@xinhuamed.com.cn.
  • Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China. Electronic address: jiang.zhilong@zs-hospital.sh.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Li, Z., Ju, X., Chen, M., Chen, Z., & Jiang, Z. (2026). Resveratrol attenuates LPS/CSE-induced macrophage ferroptosis through activation of the Nrf2-ferroportin axis. International Immunopharmacology, 189, 117380. https://doi.org/10.1016/j.intimp.2026.117380

Vancouver

Li Z, Ju X, Chen M, Chen Z, Jiang Z. Resveratrol attenuates LPS/CSE-induced macrophage ferroptosis through activation of the Nrf2-ferroportin axis. International Immunopharmacology. 2026;189:117380. doi:10.1016/j.intimp.2026.117380

BibTeX
@article{Li2026,
  author = {Li, Zhuozhe and Ju, Xu and Chen, Mengjie and Chen, Zhihong and Jiang, Zhilong},
  title = {Resveratrol attenuates LPS/CSE-induced macrophage ferroptosis through activation of the Nrf2-ferroportin axis},
  journal = {International Immunopharmacology},
  year = {2026},
  volume = {189},
  pages = {117380},
  doi = {10.1016/j.intimp.2026.117380}
}
Kostenlos starten →